Literature DB >> 2106494

Phosphorylase-cross-reactive antibodies evoked by streptococcal M protein.

J B Dale1, H S Courtney, M Kotb, D Schifferli.   

Abstract

Rabbit antisera evoked by type 5 streptococcal M protein (M5) were screened by enzyme-linked immunosorbent assay (ELISA) for immunological cross-reactivity with purified rabbit muscle phosphorylases a and b. Of 10 pep M5 antisera tested, 3 showed significant cross-reactivity with both forms of the enzyme. ELISA inhibition studies using one of the pep M5 antisera showed that all of the phosphorylase b antibodies were inhibited by pep M5, the immunogen, and phosphorylase b, the ELISA antigen. All of the antibodies were also inhibited by pep M6 and pep M19, but not by pep M24, indicating that the cross-reactive epitopes were shared by multiple serotypes of M protein. Western blot (immunoblot) analyses showed that pep M5 antisera reacted strongly with the subunit of phosphorylase b. In addition, purified phosphorylase partially inhibited the binding of pep M5 antibodies to a 95-kilodalton protein of human myocardium. One of the three cross-reactive pep M5 antisera inhibited the enzymatic activity of phosphorylase a in a dose-related fashion, reaching a maximum inhibition of 75%. The enzymatic activity in the presence of antibody was totally restored when the antiserum was first incubated with pep M5.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106494      PMCID: PMC258532          DOI: 10.1128/iai.58.3.774-778.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Repeating covalent structure of streptococcal M protein.

Authors:  E H Beachey; J M Seyer; A H Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci.

Authors:  B N Manjula; A S Acharya; S M Mische; T Fairwell; V A Fischetti
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

3.  Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules.

Authors:  B N Manjula; V A Fischetti
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

Review 4.  The structures and related functions of phosphorylase a.

Authors:  R J Fletterick; N B Madsen
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

5.  Protective antibody against a peptide fragment of type 5 streptococcal M protein cross-reacts with human heart tissue.

Authors:  J B Dale; E H Beachey
Journal:  Trans Assoc Am Physicians       Date:  1982

6.  Multiple, heart-cross-reactive epitopes of streptococcal M proteins.

Authors:  J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

7.  Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule.

Authors:  B N Manjula; V A Fischetti
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

8.  Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein.

Authors:  K F Jones; B N Manjula; K H Johnston; S K Hollingshead; J R Scott; V A Fischetti
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

9.  Protective and heart-crossreactive epitopes located within the NH2 terminus of type 19 streptococcal M protein.

Authors:  M S Bronze; E H Beachey; J B Dale
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

10.  Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen.

Authors:  E H Beachey; G H Stollerman; E Y Chiang; T M Chiang; J M Seyer; A H Kang
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.